What is VIM & VIGR?
VIM & VIGR operates at the intersection of medical-grade functionality and contemporary fashion, specializing in compression socks engineered to enhance circulation and leg health. The company addresses a diverse demographic, ranging from healthcare professionals and frequent travelers to athletes and individuals managing chronic conditions such as varicose veins or diabetes. By prioritizing both aesthetic appeal and physiological efficacy, VIM & VIGR has carved out a distinct niche in the consumer health market, moving beyond traditional clinical aesthetics to offer products that integrate seamlessly into daily wardrobes. Their commitment to high-quality materials and varied compression levels ensures that wellness remains accessible and stylish for a broad consumer base.
How much funding has VIM & VIGR raised?
VIM & VIGR has raised a total of $356K across 2 funding rounds:
Debt
$150K
Debt
$206K
Debt (2020): $150K with participation from PPP
Debt (2021): $206K led by PPP
Key Investors in VIM & VIGR
PPP
Public-Private Partnership
What's next for VIM & VIGR?
With the recent influx of capital, VIM & VIGR is poised to enter a new phase of growth, likely focusing on supply chain optimization and expanded distribution channels. As the company navigates this late-stage development, the strategic deployment of these funds will be critical in scaling their direct-to-consumer platform and potentially exploring new product lines within the therapeutic wellness space. The focus will remain on maintaining product integrity while scaling operations to meet the rising demand for health-conscious, lifestyle-oriented apparel. Future initiatives will likely involve enhancing brand visibility and deepening market penetration through targeted digital marketing and strategic retail partnerships, ensuring the company remains at the forefront of the functional fashion movement.
See full VIM & VIGR company page
